According to DeepLearning.AI, researchers have leveraged AI models trained on genomic DNA to design new bacteriophages specifically targeting E. coli, including antibiotic-resistant strains (source: DeepLearning.AI). Out of 11,000 AI-generated genome candidates, 302 were selected and 285 successfully synthesized in the lab. Experimental results demonstrated that several of these engineered phages outperformed standard phages by killing resistant E. coli more efficiently or multiplying at higher rates. This breakthrough highlights practical business opportunities in AI-driven drug discovery and synthetic biology, enabling rapid development of next-generation antimicrobial therapies and positioning AI as a crucial tool in addressing global antibiotic resistance (source: DeepLearning.AI via The Batch).